Cell Size: Putting scaling laws on a physical foundation
As a cell changes size during the cell cycle, why does its density remain constant?
- Center for Quantitative Biology, Peking University, China
- Center for Quantitative Biology and the Peking-Tsinghua Center for Life Sciences, Peking University, China
Different types of cells have different sizes, and the size of a given cell type also changes during the cell cycle. The size of a cell influences its biological functions in many ways: in large cells, for example, the protein concentration in the cytoplasm is reduced, which slows down virtually all biochemical reactions. In small cells, on the other hand, the protein concentration can become so high that proteins cannot diffuse efficiently, which also slows down reactions. Therefore, cell size must be regulated for a given cell type.
Although cell size is influenced by multiple factors – including the amounts of proteins, metabolites, and ions in the cell – some simple and universal scaling laws apply to many eukaryotic cells, including yeast and mammalian cells. In particular, the dry mass of a cell and the volume of its nucleus remain proportional to the volume of the cell as it grows during the cell cycle (Neurohr and Amon, 2020; Cantwell and Nurse, 2019; Webster et al., 2009).
These scaling laws may appear obvious to biologists as they simply suggest that the cell density and the ratio of the nuclear volume and the cell volume remain constant. From a physical perspective, however, these scaling laws are highly nontrivial. For instance, the dry mass of a cell is dominated by large biomolecules such as proteins. In contrast, the wet volume (i.e., the volume of water in the cell) is controlled by the number of small molecules, such as metabolites and ions, in the cell: this is because osmotic balance requires that the chemical potential of the water molecules inside and outside the cell must be equal. Therefore, a constant cell density suggests that protein production and small-molecule synthesis are connected. However, there are also times when the cell density does not remain constant: for example, the cytoplasm is significantly diluted in exceedingly large budding yeast cells (Neurohr et al., 2019). This dilution is thought to trigger senescence, but the mechanism responsible is not clear.
Now, in eLife, Romain Rollin, Jean-François Joanny and Pierre Sens of the Institut Curie report new insights into the scaling laws for cell size (Figure 1; Rollin et al., 2023). Their starting point was a model called the Pump-Leak model (Tosteson and Hoffman, 1960). In this model, certain charged molecules cannot pass through the cell membrane, which creates an imbalance in the osmotic pressure inside and outside the cell. Cells seek to reduce the imbalance caused by these impermeant molecules by using ion pumps to pump ions out of the cell. In the meantime, ions are also able to passively diffuse or “leak” through ion channels in the cell membrane. Throughout these processes, cells also need to maintain electroneutrality.
Figure 1
How cell density remains constant as a cell grows.
In the simplified model developed by Rollin et al., the dry volume of a cell is dominated by proteins, including ribosomes. Ions can enter and leave the cell through ion channels in the plasma membrane; ions can also be pumped out of the cell by ion pumps (bottom left). Metabolites cannot enter or leave the cell. As a cell grows (shown here schematically by the region inside the solid black line expanding to include the region inside the dashed grey line), the dry volume, which is dominated by proteins, grows exponentially with time. A constant fraction of proteins are enzymes that produce metabolites, so the number of metabolites grows at the same rate. This means that the wet volume, which is approximately proportional to the number of metabolites, also grows at the same rate. Hence, the cell density (which is basically the dry volume divided by the wet volume) remains constant.
Rollin et al. simplified the Pump-Leak model in ways that might seem crude at first sight but actually make the physical basis of cell size much more transparent. In particular, if reasonable assumptions are made about the pumping efficiency, it turns out that the wet volume of the cell is proportional to the number of impermeant molecules, which are primarily metabolites. The researchers also assumed that proteins dominate the dry mass. Furthermore, they included a model of gene expression developed by one of us (JL) and Ariel Amir (Lin and Amir, 2018) and also included protein degradation in their model. This allowed Rollin et al. to demonstrate that the number of metabolites and the total protein content scale with the ribosome number, which grows exponentially with time during the cell cycle. The cell density, therefore, remains constant. However, if the cell size becomes so large that the finite number of DNA molecules in the cell starts to limit the rate of protein production, the amount of protein saturates. However, metabolites are still produced, leading to the dilution of the cytoplasm. Encouragingly, the predictions of this updated Pump-Leak model quantitatively fit data on cell density in budding yeast (Neurohr et al., 2019).
Rollin et al. then explored the rapid swelling that takes places in mammalian cells at the start of mitosis, before being reversed later in the cell cycle (Son et al., 2015; Zlotek-Zlotkiewicz et al., 2015). They propose that counterions released by chromatin are responsible for the swelling, and their estimate for the increase in the cell volume (between ~100µm3 and ~150µm3) is consistent with the ~10% increase that is typically seen in experiments.
The researchers also demonstrated that metabolites are crucial in setting the ratio of the nuclear volume to the cytoplasmic volume. Based on a nested Pump-Leak model, Rollin et al. went on to show that the ratio of these volumes was equal to the ratio of the protein contents of the nucleus and cytoplasm, so long as the chromatin charge density was low enough. And by demonstrating that cells typically contain a large pool of metabolites, which results in large cell volumes and low chromatin charge densities, they shed light on why the nuclear-cytoplasmic volume ratio remains constant.
By making biologically reasonable assumptions to simplify the classic Pump-Leak model, Rollin, Joanny and Sens have been able to deepen our understanding of various phenomena related to cell size, and to make predictions about the breakdown of the cell size scaling laws that could be tested in experiments.
References
-
Unravelling nuclear size controlCurrent Genetics 65:1281–1285.https://doi.org/10.1007/s00294-019-00999-3
-
Homeostasis of protein and mRNA concentrations in growing cellsNature Communications 9:4496.https://doi.org/10.1038/s41467-018-06714-z
-
Relevance and regulation of cell densityTrends in Cell Biology 30:213–225.https://doi.org/10.1016/j.tcb.2019.12.006
-
Resonant microchannel volume and mass measurements show that suspended cells swell during mitosisJournal of Cell Biology 211:757–763.https://doi.org/10.1083/jcb.201505058
-
Regulation of cell volume by active cation transport in high and low potassium sheep red cellsJournal of General Physiology 44:169–194.https://doi.org/10.1085/jgp.44.1.169
-
Sizing up the nucleus: Nuclear shape, size and nuclear-envelope assemblyJournal of Cell Science 122:1477–1486.https://doi.org/10.1242/jcs.037333
-
Optical volume and mass measurements show that mammalian cells swell during mitosisJournal of Cell Biology 211:765–774.https://doi.org/10.1083/jcb.201505056
Article and author information
Author details
Publication history
Copyright
© 2023, Ye and Lin
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,180
- views
-
- 106
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Cell Size: Putting scaling laws on a physical foundation
eLife 12:e89415.
https://doi.org/10.7554/eLife.89415
Further reading
-
- Cancer Biology
- Cell Biology
Testicular microcalcifications consist of hydroxyapatite and have been associated with an increased risk of testicular germ cell tumors (TGCTs) but are also found in benign cases such as loss-of-function variants in the phosphate transporter SLC34A2. Here, we show that fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, is expressed in testicular germ cell neoplasia in situ (GCNIS), embryonal carcinoma (EC), and human embryonic stem cells. FGF23 is not glycosylated in TGCTs and therefore cleaved into a C-terminal fragment which competitively antagonizes full-length FGF23. Here, Fgf23 knockout mice presented with marked calcifications in the epididymis, spermatogenic arrest, and focally germ cells expressing the osteoblast marker Osteocalcin (gene name: Bglap, protein name). Moreover, the frequent testicular microcalcifications in mice with no functional androgen receptor and lack of circulating gonadotropins are associated with lower Slc34a2 and higher Bglap/Slc34a1 (protein name: NPT2a) expression compared with wild-type mice. In accordance, human testicular specimens with microcalcifications also have lower SLC34A2 and a subpopulation of germ cells express phosphate transporter NPT2a, Osteocalcin, and RUNX2 highlighting aberrant local phosphate handling and expression of bone-specific proteins. Mineral disturbance in vitro using calcium or phosphate treatment induced deposition of calcium phosphate in a spermatogonial cell line and this effect was fully rescued by the mineralization inhibitor pyrophosphate. In conclusion, testicular microcalcifications arise secondary to local alterations in mineral homeostasis, which in combination with impaired Sertoli cell function and reduced levels of mineralization inhibitors due to high alkaline phosphatase activity in GCNIS and TGCTs facilitate osteogenic-like differentiation of testicular cells and deposition of hydroxyapatite.
-
- Cell Biology
- Genetics and Genomics
A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.
